New issues in assessing biotech sector: Some empirical evidences and policy implications

R. D'AMORE, DISES/UNIVERSITY OF SALERNO, ITALY
M. P. VITTORIA, IRAT/CNR, ITALY

Abstract: A common view among many academics and policy makers is that biotech offer enormous opportunities for improving competitiveness and economic growth. For this reason there is a growing need to set up appropriate policy to improve the adoption and diffusion of biotech innovation. Nevertheless, there are many interpretative problems about the identification of the biotech firm, due to the uncertainty about the border of the sector itself. The main objective of this paper is to provide a contribution to better define biotech industry considering the pervasive nature of innovation in this sector. The paper provides an Italian data set survey and a new data base consistent with OECD statistical standards. The paper includes both an evaluation of the degree of functionality of the OECD firm classification on our data and an information source survey for statistical indicators for the main policy areas.
Keywords: Biotech innovation, Italian biotech industry, Industry assessment, OECD statistical model, Policy indicators

Outlook 2008_Dâ--Amore_Vittoria-Itemid=.pdf
Outlook 2008_Dâ--Amore_Vittoria-Itemid=.pdf
Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Email this to someonePrint this page

Please note, you need to be a WASD member to login and download publications. Logged-in members will see a 'Download' button in the box above.

If you do not have a login, you can register to become a member.

If you are are already a member, please login below.

Login

Be the first to comment

Leave a Reply

Your email address will not be published.


*